Kastamonu University has achieved another significant success in the field of health technologies. The project titled "Development of a Rapid ApoB-100 Test Kit," which has been awarded support under the 2025-B-01 call by the Turkish Health Institutes Presidency (TÜSEB), aims to add a new dimension to digital diagnostic technologies.

In the project led by Prof. Dr. Özgür Kaynar, Dean of the Faculty of Veterinary Medicine, Assoc. Prof. Dr. Seçkin Özkanlar from Atatürk University and Assist.Prof.Dr. Dilara Kaynar from Kastamonu University Devrekani Vocational School are also involved.

 In the project, which is being implemented with a budget of approximately 1 million 800 thousand TL, an innovative rapid diagnostic kit that allows quantitative ApoB100 measurement using smartphones will be developed. With this technology, it is aimed to provide a low-cost, easily accessible, and user-friendly diagnostic tool for the early detection of cardiovascular disease risk. Within the scope of the project, a new technique will be used for the first time, which, unlike traditional lateral flow immunoassays, allows for the high-precision transfer of antibodies to only a specific area on the nitrocellulose membrane, preserves the natural structure of the antibodies, and minimizes the risk of contamination.

 The test kit to be developed will be designed to measure ApoB100 levels above 80 mg/dL, and it will be optimized to the 130 mg/dL level to ensure clinical accuracy.

 Kastamonu University Rector Prof. Dr. Ahmet Hamdi Topal evaluated the TÜSEB-supported project and stated the following: "As a university, we value the aspects of scientific research that touch the field and contribute to human life." This project is extremely valuable in terms of developing early diagnosis opportunities for public health, as well as the digital transformation of diagnostic technologies. I congratulate our project coordinator, Prof. Dr. Özgür Kaynar, and the entire project team, and wish them continued success.